Key biomarkers in type 2 diabetes patients: A systematic review
Study context
- Population
- T2D patients and controls aged 30–90 years, clinical reports over the past 11 years
- Participants
- 24,001 patients
- Comparison
- T2D patients vs controls
- T2Dn = 10,024
- Controls (CTL)n = 13,977reference
- Outcome
- Biomarker profiles in T2D vs controls
Pooled result
As reported in the abstract
- Haematological profile (1084 cases vs. 1458 CTL): increased white blood cell and platelet counts, decreased red blood cell counts and iron absorption
- Serum protein profile (6753 cases vs. 9613 CTL): reduced albumin, increased globulin
- Cytokines (975 cases vs. 1350 CTL): reduced anti-inflammatory and increased pro-inflammatory cytokines
- Lipid profile (1212 cases vs. 1556 CTL): decreased high-density lipoprotein (HDL), increased low-density lipoprotein (LDL) and TG
Original publication
Key biomarkers in type 2 diabetes patients: A systematic review. Diabetes Obes Metab. Published 2 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →